Riskpilot← Back to searchSign inGet full accessERLAND HANSEN AS
ASActiveOrg 942497792Storgata 124D, 3915 PorsgrunnRetail sale of medical and orthopaedic goods · NACE 4774Est. 198714 employees
Revenue 2024
NOK 22,8M
+15% vs 2023
EBITDA margin
5.2%
+51% vs 2023
Equity ratio
16.9%
Financial strength
Net profit 2024
NOK 191K
0% vs 2023
| Revenue | NOK 22,8M | +15% |
| EBITDA | NOK 1,2M | +51% |
| Net profit | NOK 191K | +0% |
| Total assets | NOK 6,1M | -1% |
| Equity | NOK 1M | -5% |
| Employees | 14 | — |
Legal name
ERLAND HANSEN AS
Org number
942497792
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
23. februar 1987
Share capital
—
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Address
Storgata 124D, 3915 Porsgrunn
Phone
+4735551619
Email
butikk.porsgrunn@st.no.specsavers.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 304 | 18 046 | 18 555 | 19 789 | 22 822 |
| Staff expenses | −4 514 | −5 453 | −6 016 | −6 734 | −7 731 |
| EBITDA | 1 695 | 1 706 | 1 278 | 783 | 1 179 |
| Depreciation & amort. | −280 | −170 | −152 | −502 | −828 |
| EBIT | 1 415 | 1 536 | 1 125 | 281 | 351 |
| Net financials | 1 | 0 | 0 | −89 | −121 |
| Profit before tax | 1 415 | 1 536 | 1 125 | 192 | 230 |
| Tax | 349 | 349 | 252 | −0 | 39 |
| Net profit | 1 066 | 1 187 | 873 | 192 | 191 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 629 | 4 366 | 4 142 | 6 216 | 6 145 |
| Equity | 593 | 980 | 1 103 | 1 095 | 1 036 |
| Long-term debt | 0 | 0 | 0 | 2 480 | 1 771 |
| Short-term debt | 3 036 | 3 386 | 3 039 | 2 641 | 3 337 |
| Total debt | 3 036 | 3 386 | 3 039 | 5 121 | 5 109 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20202024
Equity ratio
16.9%
This company
38.2%
Market median
-56% vs market
20202024
Return on equity
18.5%
This company
18.4%
Market median
+1% vs market
20202024
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20202024
Asset turnover
3.71×
This company
1.12×
Market median
+231% vs market
20202024
Debt / equity
4.93×
This company
0.62×
Market median
-695% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2019 | |
| Board of Directors | 2025 | |
| Chairman | 2019 | |
| Former (2) | ||
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2019 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40% | 40% | 2024 | |
| Company | 40% | 40% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lintrup As
ERLAND HANSEN AS Board members of ERLAND HANSEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingeborg Lintrup | Board of Directors | 0 companies |
| Ingeborg Lintrup Weie | Board of Directors | 0 companies |
| Ane Randulff | Board of Directors | 0 companies |
| Erik Haukaas Bjerkreim | Chairman | 0 companies |
| Endre Gorm Randulff | Board of Directors | 0 companies |